Liaoning Cheng Da Co Ltd
SSE:600739
Liaoning Cheng Da Co Ltd's latest stock split occurred on Jul 1, 2011
The company executed a 3-for-2 stock split, meaning that for every 2 shares held, investors received 3 new shares.
The adjusted shares began trading on Jul 1, 2011. This was Liaoning Cheng Da Co Ltd's 8th stock split, following the previous one in May 22, 2007.
BGLC
ATORX
TGL
Liaoning Cheng Da Co Ltd
Glance View
Liaoning Cheng Da Co Ltd stands as a significant player in the landscape of Chinese conglomerates, weaving a diverse portfolio that strategically aligns with the economic growth patterns of the region. Founded in the bustling province of Liaoning, the company epitomizes a model of diversified investment, underpinning its operations with a well-considered spread across various sectors. Initially, it carved a niche in the trading business, leveraging the abundant natural resources and industrial outputs of its home province to build a steady stream of revenue. This foundation allowed Cheng Da to expand into pharmaceuticals, real estate, and financial investments, each segment contributing distinctively to the company’s overall robustness. Cheng Da’s pharmaceutical business has emerged as a cornerstone, thriving amidst the rising demand for healthcare products in China. This arm of the company is particularly adept in leveraging advanced research methodologies combined with traditional Chinese medicine, thus creating a distinctive edge in both domestic and international markets. Meanwhile, its real estate ventures capably ride the wave of urbanization in China, focusing on premium residential and commercial properties, enhancing the urban landscape while adding to its financial metrics. By sitting at the crossroads of critical sectoral developments and maintaining a keen eye on expansive opportunities, Liaoning Cheng Da Co Ltd astutely navigates the intricate dance of market dynamics, thus cementing its place as a formidable entity in the economic engine of China.
You don't have any saved screeners yet